SEARCH · PubMed Health
Results for “Serial Publications”
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Publishing nutrition research: a review of study design, statistical analyses, and other key elements of manuscript preparation, Part 1.
To enhance the Journal's position as the premier source for peer-reviewed research in the science of food, nutrition, and dietetics, members of the Board of Editors recognize the importance of providing a resource for researchers to ensure quality and accuracy of reporting in the Journal. This first monograph of a periodic four-part series focuses on the study hypothesis, study design, and collaboration with a statistician. The basics of study design start with a clear hypothesis or research question and a definitive outcome measure. Throughout the development of a research project, the questions of what is to be discovered and why the research is being conducted need to be addressed. Decisions about parameters to measure and study design most appropriate to test a hypothesis create the foundation for future conclusions. Collaboration with a statistician can aid in the research development process. Documentation that coherently communicates the research process will advance the science of evidence-based practice in nutrition and dietetics. Real examples from published literature are provided, as well as references to books and online resources.
Sketches from The Lancet. Venereal diseases.
Explore the source record for details and available documents.
The journal "impact factor": a misnamed, misleading, misused measure.
The Institute for Scientific Information (ISI), a database publishing company that publishes Current Contents and Science Citation Index, has devised and promulgated what it terms the journal "impact factor." ISI describes this factor as a "measure of the frequency with which the 'average article' in a journal has been cited in a particular year." The factor is a ratio between citations and recent citable published items calculated by dividing the number of all current citations of items published in a journal during the preceding 2 years by the number of articles published in those 2 years by that journal. What, if anything, is wrong with the "impact factor"? There is absolutely nothing incorrect with the calculation of the ratio itself. However, the "impact factor" is misnamed and misleading. Being misnamed and misleading, the "impact factor" has been misused. It is being held out as a measure of the importance of a specific journal article and the journal in which the article appeared. By extension, the "impact factor" is also being misused to gauge the relative importance of individual researchers, research programs, and even the institution hosting the research. We recommend that the term "impact factor" be abolished and that this measure be renamed in keeping with its actual role, that merely of a time-specific "citation rate index" and nothing more. What is currently called the "impact factor" should not be misused to evaluate journals or to validate the scientific relevance of a particular researcher or research program, especially in decisions regarding employment, funding, and tenure.
Reader reaction and AJIC editorial board response: strategic directions for the journal.
Explore the source record for details and available documents.
Biology of the Cell-new team, new topics, new look.
Explore the source record for details and available documents.
Favourite papers in infectious diseases 2004.
Explore the source record for details and available documents.
Favourite papers in infectious diseases 2005.
Explore the source record for details and available documents.
Canada tops cancer research impact list.
Explore the source record for details and available documents.
The Cochrane Library: more systematic reviews on nutrition needed.
The knowledge and relevance of nutrition as well as the demand for well-funded advices increase. The Cochrane Collaboration plays a leading role within the evidence-based medicine and practice. We advocate therefore more specialized nutritional interest within the Cochrane Collaboration. In case 'Nutrition' needs more attention within the Cochrane Library, one of the first priorities is deciding about whether to include non-randomized studies into the Specialized Register and generating lists of journals to handsearch for such a Specialized Register. Preparatory to these activities an inventory of Nutritional content within the Cochrane Library is needed. We estimate that reviews directly related to nutrition and those of borderline interest to nutrition represent less than 4% of all published reviews in The Cochrane Library.
Citation analysis and journal impact factors in ophthalmology and vision science journals.
Citation analysis has evolved over the last 50 years as one parameter for assessing the quality of research published in scientific, technology and social science journals. This is based on the assumption that influential research is widely cited by other scientists and clinicians. With the advent of the Internet, Journal Citation Reports from the Institute for Scientific Information (ISI-JCR) have become widely available to individuals and institutions. In an increasingly competitive research environ-ment, aspects of citation analysis have been suggested as simple proxy, objective measures to evaluate the research quality of a journal, published articles, research institutions and even individual researchers. This review article provides an overview of citation analysis, including definitions, uses of these reports, and related controversies and potential abuses. As it has become the most commonly used indicator, there is a particular focus on the use of the Journal Impact Factor (JIF). This is a widely quoted measure indicating the frequency with which the average article published in a journal of interest will be quoted within a specified time frame that therefore allows approximate comparisons of journals within a particular field of interest. Given the relative paucity of information in this area, emphasis is placed on citation analysis within ophthalmology, in particular in regard to the 43 ophthal-mology, vision science and optometry journals that are listed in the ISI-JCR 2001 reports.
Adrenaline or epinephrine? The naming of drugs - a problem of harmonisation for scientific journals.
Explore the source record for details and available documents.
On the periphery: Nature questions the role of women in science.
Explore the source record for details and available documents.
Trends in contrast media research.
Explore the source record for details and available documents.
A retrospective look at the Journal of Developmental and Behavioral Pediatrics.
Explore the source record for details and available documents.
Petsavers--funding research projects.
Explore the source record for details and available documents.
Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma.
PURPOSE: Mesothelin is an emerging marker for cancer diagnosis and target-based therapy, yet relatively little is known about the clinical significance of mesothelin expression in tumors. In this study, we correlate mesothelin immunoreactivity to clinicopathologic features in ovarian serous carcinoma. EXPERIMENTAL DESIGN: Mesothelin expression levels were compared among 81 publicly available serial analysis of gene expression (SAGE) libraries of various carcinoma and normal tissue types. Immunohistochemistry using a well-characterized mesothelin monoclonal antibody (5B2) was done to evaluate mesothelin expression in 167 high-grade and 31 low-grade ovarian serous carcinomas. Immunohistochemistry staining scores were correlated with patient survival, tumor site, tumor grade, in vitro drug resistance, and differentiation status of tumor cells. RESULTS: SAGE analysis showed that mesothelin was overexpressed in 50% of ovarian and pancreatic carcinomas but rarely in other cancer types, including liver, colon, kidney, prostate, and breast. Mesothelin immunoreactivity (>5% of tumor cells) was present in 55% of ovarian serous carcinomas with no difference in expression between high-grade and low-grade serous tumors (P = 0.82). Based on Kaplan-Meier analysis, we found that a diffuse mesothelin staining (>50% of tumor cells) in primary high-grade ovarian carcinomas correlated significantly with prolonged survival in patients who had advanced-stage disease and had received optimal debulking surgery followed by chemotherapy (P = 0.023). Mesothelin expression did not correlate significantly with patient age, tumor site, in vitro drug resistance, or tumor differentiation status (P > 0.10). CONCLUSION: Our results provided new evidence that mesothelin expression is associated with prolonged survival in patients with high-grade ovarian serous carcinoma.